Thymoquinone: A Promising Therapeutic Agent for the Treatment of Colorectal Cancer

被引:9
|
作者
Kurowska, Natalia [1 ]
Madej, Marcel [1 ,2 ]
Strzalka-Mrozik, Barbara [1 ]
机构
[1] Med Univ Siles, Fac Pharmaceut Sci Sosnowiec, Dept Mol Biol, PL-40055 Katowice, Poland
[2] Med Univ Silesia, Ctr Res & Implementat, Siles LabMed, PL-40752 Katowice, Poland
关键词
Nigella sativa; thymoquinone; colorectal cancer; adjuvant therapy; anticancer therapy; 5-FU resistance; NIGELLA-SATIVA L; LOVO COLON-CANCER; ANTICANCER THYMOQUINONE; OXIDATIVE STRESS; CELL-DEATH; APOPTOSIS; EXTRACTION; 5-FLUOROURACIL; INHIBITION; SEEDS;
D O I
10.3390/cimb46010010
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Colorectal cancer (CRC) is one of the most commonly diagnosed cancers and is responsible for approximately one million deaths each year. The current standard of care is surgical resection of the lesion and chemotherapy with 5-fluorouracil (5-FU). However, of concern is the increasing incidence in an increasingly younger patient population and the ability of CRC cells to develop resistance to 5-FU. In this review, we discuss the effects of thymoquinone (TQ), one of the main bioactive components of Nigella sativa seeds, on CRC, with a particular focus on the use of TQ in combination therapy with other chemotherapeutic agents. TQ exhibits anti-CRC activity by inducing a proapoptotic effect and inhibiting proliferation, primarily through its effect on the regulation of signaling pathways crucial for tumor progression and oxidative stress. TQ can be used synergistically with chemotherapeutic agents to enhance their anticancer effects and to influence the expression of signaling pathways and other genes important in cancer development. These data appear to be most relevant for co-treatment with 5-FU. We believe that TQ is a suitable candidate for consideration in the chemoprevention and adjuvant therapy for CRC, but further studies, including clinical trials, are needed to confirm its safety and efficacy in the treatment of cancer.
引用
收藏
页码:121 / 139
页数:19
相关论文
共 50 条
  • [41] Tucatinib: an investigational novel therapeutic agent for the treatment of HER-2 colorectal cancer
    Ahn, Daniel
    Walden, Daniel
    Bekaii-Saab, Tanios
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2022, 31 (05) : 437 - 441
  • [42] Therapeutic implications and clinical manifestations of thymoquinone
    Alam, Manzar
    Hasan, Gulam Mustafa
    Ansari, Md Meraj
    Sharma, Rishi
    Yadav, Dharmendra Kumar
    Hassan, Md Imtaiyaz
    PHYTOCHEMISTRY, 2022, 200
  • [43] Circular RNA: A promising new star for the diagnosis and treatment of colorectal cancer
    Zhang, Shunhao
    Sun, Jing
    Gu, Minqi
    Wang, Guihua
    Wang, Xudong
    CANCER MEDICINE, 2021, 10 (24): : 8725 - 8740
  • [44] Boric acid as a promising agent in the treatment of ovarian cancer: Molecular mechanisms
    Cabus, Umit
    Secme, Mucahit
    Kabukcu, Cihan
    Cil, Nazli
    Dodurga, Yavuz
    Mete, Gulcin
    Fenkci, Ibrahim Veysel
    GENE, 2021, 796
  • [45] Xanthohumol: An underestimated, while potent and promising chemotherapeutic agent in cancer treatment
    Vesaghhamedani, Shadi
    Ebrahimzadeh, Farnoosh
    Najafi, Elnaz
    Shabgah, Omid Gohari
    Askari, Elham
    Shabgah, Arezoo Gowhari
    Mohammadi, Hamed
    Jadidi-Niaragh, Farhad
    Navashenaq, Jamshid Gholizadeh
    PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY, 2022, 172 : 3 - 14
  • [46] Thymoquinone: A promising anti-cancer drug from natural sources
    Gali-Muhtasib, Hala
    Roessner, Albert
    Schneider-Stock, Regine
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2006, 38 (08): : 1249 - 1253
  • [47] Targeting cancer stem cells as therapeutic approach in the treatment of colorectal cancer
    Parizadeh, Seyed Mostafa
    Jafarzadeh-Esfehani, Reza
    Hassanian, Seyed Mandi
    Parizadeh, Seyed Mohammad Reza
    Vojdani, Samaneh
    Ghandehari, Maryam
    Ghazaghi, Anahita
    Khazaei, Majid
    Shahidsales, Soodabeh
    Rezayi, Majid
    Asgharzadeh, Fereshteh
    Ghayour-Mobarhan, Majid
    Ferns, Gordon A.
    Avan, Amir
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2019, 110 : 75 - 83
  • [48] PI3K-AKT Pathway Modulation by Thymoquinone Limits Tumor Growth and Glycolytic Metabolism in Colorectal Cancer
    Karim, Shahid
    Burzangi, Abdulhadi S.
    Ahmad, Aftab
    Siddiqui, Nasir Ali
    Ibrahim, Ibrahim M.
    Sharma, Priyanka
    Abualsunun, Walaa A.
    Gabr, Gamal A.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (04)
  • [49] Promotion of Autophagy and Apoptosis in Colorectal Cancer Exposed to Imatinib and Thymoquinone
    El-Khouly, Dalia
    Thabet, Nadia A.
    Sayed-Ahmed, Mohamed
    Omran, Mervat M.
    JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY, 2025, 39 (04)
  • [50] Thymoquinone: Potential cure for inflammatory disorders and cancer
    Woo, Chern Chiuh
    Kumar, Alan Prem
    Sethi, Gautam
    Tan, Kwong Huat Benny
    BIOCHEMICAL PHARMACOLOGY, 2012, 83 (04) : 443 - 451